BiotechTube
Home/ARC Therapies/前田 優香 (Yuka Maeda)
前優

前田 優香 (Yuka Maeda)

Director, National Cancer Center Unit Leader

ARC Therapies

Therapeutic Areas

Oncology

ARC Therapies Pipeline

DrugIndicationPhase
ATLL Cell TherapyAdult T-cell Leukemia/Lymphoma (ATLL)Preclinical
YB328 Microbiome ProgramCancer ImmunotherapyResearch

Leadership Team at ARC Therapies

鈴蘭
鈴木 蘭美 (Ranmi Suzuki)
CEO, Representative Director, President
渡慶
渡邊 慶介 (Keisuke Watanabe)
Director, National Cancer Center Principal Investigator
武行
武本 行弘 (Yukihiro Takemoto)
COO
横雅
横山 雅彦 (Masahiko Yokoyama)
CFO
View full ARC Therapies profile